المؤلفون: Thompson, AAR, Dickinson, RS, Murphy, F, Thomson, JP, Marriott, HM, Tavares, A, Willson, J, Williams, L, Lewis, A, Mirchandani, A, Coelho, PD, Doherty, C, Ryan, E, Watts, E, Morton, NM, Forbes, S, Stimson, RH, Hameed, AG, Arnold, N, Preston, JA, Lawrie, A, Finisguerra, V, Mazzone, M, Sadiku, P, Goveia, J, Taverna, F, Carmeliet, P, Foster, SJ, Chilvers, ER, Cowburn, AS, Dockrell, DH, Johnson, RS, Meehan, RR, Whyte, MKB, Walmsley, SR

المصدر: Science immunology. 2(8)

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:138471367

المؤلفون: M. A. Nafeh, Ahmad Ya, Abdul-Hameed Ag, G T Strickland, Ahmed Medhat, Rashwan Nm

المصدر: The American Journal of Tropical Medicine and Hygiene. 47:470-477

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Abdominal pain, Tuberculosis, Adolescent, Pleural effusion, Biopsy, Antitubercular Agents, Peritonitis, Tuberculous, Peritonitis, Pallor, Sex Factors, Virology, Ascites, medicine, Humans, Prospective Studies, Child, Laparoscopy, Granuloma, medicine.diagnostic_test, business.industry, Mycobacterium tuberculosis, Middle Aged, medicine.disease, Surgery, Infectious Diseases, Evaluation Studies as Topic, Egypt, Female, Parasitology, medicine.symptom, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd4c773ca35db11844129ae0bb7185cd
https://doi.org/10.4269/ajtmh.1992.47.470

المؤلفون: Thompson, AAR, Dickinson, RS, Murphy, F, Thomson, JP, Marriott, HM, Tavares, A, Willson, J, Williams, L, Lewis, A, Mirchandani, A, Dos Santos Coelho, P, Doherty, C, Ryan, E, Watts, E, Morton, NM, Forbes, S, Stimson, RH, Hameed, AG, Arnold, N, Preston, JA, Lawrie, A, Finisguerra, V, Mazzone, M, Sadiku, P, Goveia, J, Taverna, F, Carmeliet, P, Foster, SJ, Chilvers, ER, Cowburn, AS, Dockrell, DH, Johnson, RS, Meehan, RR, Whyte, MKB, Walmsley

مصطلحات موضوعية: Basic Science, 1108 Medical Microbiology, 2.1 Biological and endogenous factors, Infection, 3. Good health

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a523f3b9b26a8e6c4a56f3d420405739

المؤلفون: Garg P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England. Pankaj.Garg@nhs.net.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England. Pankaj.Garg@nhs.net., Lewis RA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Johns CS; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England., Capener D; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England., Rajaram S; Sheffield Teaching Hospitals NHS Foundation Trust, London, England., Thompson AAR; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Condliffe R; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Elliot CA; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Charalampopoulos A; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Hameed AG; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Rothman A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England.; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S102JF, England., Kiely DG; Sheffield Teaching Hospitals NHS Foundation Trust, London, England.; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, S10 2JF, England.

المصدر: The international journal of cardiovascular imaging [Int J Cardiovasc Imaging] 2021 Oct; Vol. 37 (10), pp. 3019-3025. Date of Electronic Publication: 2021 May 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 100969716 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8312 (Electronic) Linking ISSN: 15695794 NLM ISO Abbreviation: Int J Cardiovasc Imaging Subsets: MEDLINE

مواضيع طبية MeSH: Heart Failure*/diagnostic imaging , Hypertension, Pulmonary*/diagnostic imaging , Ventricular Dysfunction, Right*/diagnostic imaging, Humans ; Magnetic Resonance Imaging, Cine ; Magnetic Resonance Spectroscopy ; Predictive Value of Tests ; Prognosis ; Stroke Volume ; Ventricular Function, Left ; Ventricular Function, Right

المؤلفون: Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Armstrong I; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Bergbaum C; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Brewis MJ; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK., Cannon J; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Church AC; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK., Coghlan JG; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK., Davies RJ; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., Dimopoulos K; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Gibbs JSR; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., Gin-Sing W; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., Haji G; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., Hameed AG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Howard LS; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., Johnson MK; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK., Kempny A; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Lo Giudice F; National Pulmonary Hypertension Service, Hammersmith Hospital, London, UK., McCabe C; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Peacock AJ; Scottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK., Peleyeju O; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK., Pepke-Zaba J; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Polwarth G; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Price L; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Schreiber BE; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK., Sheares K; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Taboada D; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK.; Dept of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Toshner MR; Pulmonary Vascular Disease Unit, Royal Papworth Hospital, Cambridge, UK., Wanjiku I; Pulmonary Hypertension Unit, Royal Free Hospital, London, UK., Wort SJ; National Pulmonary Hypertension Service, Royal Brompton Hospital and Imperial College, London, UK., Yorke J; School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK robin.condliffe@nhs.net.

المصدر: The European respiratory journal [Eur Respir J] 2021 Feb 25; Vol. 57 (2). Date of Electronic Publication: 2021 Feb 25 (Print Publication: 2021).

نوع المنشور: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

مواضيع طبية MeSH: Connective Tissue Diseases*/complications , Hypertension, Pulmonary* , Pulmonary Arterial Hypertension*, Humans ; Quality of Life ; United Kingdom

المؤلفون: Lewis RA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Billings CG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Hurdman JA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Smith IA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Austin M; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Armstrong IJ; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Middleton J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Rothman AMK; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Harrington J; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hamilton N; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Hameed AG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Thompson AAR; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Charalampopoulos A; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Elliot CA; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Sabroe I; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and., Wild JM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Swift AJ; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom., Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom., Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals National Health Service Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom.; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Medical School, Sheffield, United Kingdom; and.; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, United Kingdom.

المصدر: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2021 Jan; Vol. 18 (1), pp. 34-43.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Thoracic Society Country of Publication: United States NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE

مواضيع طبية MeSH: Exercise Test* , Pulmonary Arterial Hypertension* , Walk Test*, Humans

المؤلفون: Arnold ND; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Pickworth JA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., West LE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Dawson S; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Carvalho JA; Kymab Ltd, Babraham Research Campus, Cambridge, CB22 3AT, UK., Casbolt H; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Braithwaite AT; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Iremonger J; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Renshall L; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Germaschewski V; Kymab Ltd, Babraham Research Campus, Cambridge, CB22 3AT, UK., McCourt M; Kymab Ltd, Babraham Research Campus, Cambridge, CB22 3AT, UK., Bland-Ward P; Kymab Ltd, Babraham Research Campus, Cambridge, CB22 3AT, UK., Kowash H; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Hameed AG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Rothman AMK; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Frid MG; Cardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA., Roger Thompson AA; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Evans HR; Department of Chemistry, University of Sheffield, Sheffield, S3 7HF, UK., Southwood M; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospital, Cambridge, CB2 0QQ, UK., Morrell NW; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's and Papworth Hospital, Cambridge, CB2 0QQ, UK., Crossman DC; School of Medicine, University of St. Andrews, St, Andrews, KY16 9AJ, UK., Whyte MKB; MRC/University of Edinburgh Centre for Inflammation Research, University of Edinburgh, The Queens Medical Research Institute, Edinburgh, EH16 4TJ, UK., Stenmark KR; Cardiovascular Pulmonary Research Laboratories, Departments of Pediatrics and Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA., Newman CM; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Kiely DG; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK.; Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals Foundation Trust, Royal Hallamshire Hospital, Sheffield, S10 2JF, UK., Francis SE; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK., Lawrie A; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, S10 2RX, UK. a.lawrie@sheffield.ac.uk.

المصدر: Nature communications [Nat Commun] 2019 Nov 15; Vol. 10 (1), pp. 5183. Date of Electronic Publication: 2019 Nov 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies/*administration & dosage , Familial Primary Pulmonary Hypertension/*drug therapy , Osteoprotegerin/*metabolism, Animals ; Cell Movement/drug effects ; Disease Models, Animal ; Familial Primary Pulmonary Hypertension/genetics ; Familial Primary Pulmonary Hypertension/metabolism ; Familial Primary Pulmonary Hypertension/physiopathology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Myocytes, Smooth Muscle/cytology ; Myocytes, Smooth Muscle/metabolism ; Osteoprotegerin/genetics ; Protein Binding ; Pulmonary Artery/cytology ; Pulmonary Artery/metabolism ; Pulmonary Artery/physiopathology ; Rats ; Rats, Wistar ; Vascular Remodeling/drug effects

المؤلفون: Hameed AG; Department of Cardiovascular Science, 2 Department of Neuroscience, University of Sheffield, S10 2RX Sheffield, UK., Arnold ND, Chamberlain J, Pickworth JA, Paiva C, Dawson S, Cross S, Long L, Zhao L, Morrell NW, Crossman DC, Newman CM, Kiely DG, Francis SE, Lawrie A

المصدر: The Journal of experimental medicine [J Exp Med] 2012 Oct 22; Vol. 209 (11), pp. 1919-35. Date of Electronic Publication: 2012 Oct 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies/*pharmacology , Hypertension, Pulmonary/*prevention & control , Myocytes, Smooth Muscle/*drug effects , TNF-Related Apoptosis-Inducing Ligand/*antagonists & inhibitors, Adult ; Animals ; Antibodies/immunology ; Apolipoproteins E/genetics ; Apolipoproteins E/metabolism ; Apoptosis/drug effects ; Blotting, Western ; Cell Proliferation/drug effects ; Cells, Cultured ; Female ; Gene Expression/drug effects ; Humans ; Hypertension, Pulmonary/genetics ; Hypertension, Pulmonary/physiopathology ; Hypoxia/physiopathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Middle Aged ; Muscle, Smooth, Vascular/drug effects ; Muscle, Smooth, Vascular/metabolism ; Muscle, Smooth, Vascular/pathology ; Myocytes, Smooth Muscle/metabolism ; Pulmonary Artery/drug effects ; Pulmonary Artery/physiopathology ; Rats, Sprague-Dawley ; Reverse Transcriptase Polymerase Chain Reaction ; TNF-Related Apoptosis-Inducing Ligand/genetics ; TNF-Related Apoptosis-Inducing Ligand/immunology ; Young Adult

المؤلفون: Condliffe R; Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, UK., Pickworth JA, Hopkinson K, Walker SJ, Hameed AG, Suntharaligam J, Soon E, Treacy C, Pepke-Zaba J, Francis SE, Crossman DC, Newman CM, Elliot CA, Morton AC, Morrell NW, Kiely DG, Lawrie A

المصدر: Pulmonary circulation [Pulm Circ] 2012 Jan-Mar; Vol. 2 (1), pp. 21-7.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101557243 Publication Model: Print Cited Medium: Internet ISSN: 2045-8940 (Electronic) Linking ISSN: 20458932 NLM ISO Abbreviation: Pulm Circ Subsets: PubMed not MEDLINE

المؤلفون: Lawrie A; Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom. a.lawrie@sheffield.ac.uk, Hameed AG, Chamberlain J, Arnold N, Kennerley A, Hopkinson K, Pickworth J, Kiely DG, Crossman DC, Francis SE

المصدر: The American journal of pathology [Am J Pathol] 2011 Oct; Vol. 179 (4), pp. 1693-705. Date of Electronic Publication: 2011 Aug 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0370502 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-2191 (Electronic) Linking ISSN: 00029440 NLM ISO Abbreviation: Am J Pathol Subsets: MEDLINE

مواضيع طبية MeSH: Apolipoproteins E/*deficiency , Diet, High-Fat/*adverse effects , Hypertension, Pulmonary/*pathology , Interleukin-1/*metabolism, Animals ; Apolipoproteins E/metabolism ; Biomarkers/metabolism ; Disease Progression ; Feeding Behavior/drug effects ; Hemodynamics/drug effects ; Hypertension, Pulmonary/complications ; Hypertension, Pulmonary/drug therapy ; Hypertension, Pulmonary/physiopathology ; Hypertrophy, Right Ventricular/complications ; Hypertrophy, Right Ventricular/pathology ; Hypertrophy, Right Ventricular/physiopathology ; Inflammation Mediators/metabolism ; Interleukin 1 Receptor Antagonist Protein/pharmacology ; Interleukin 1 Receptor Antagonist Protein/therapeutic use ; Lung/drug effects ; Lung/pathology ; Lung/physiopathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Organ Size/drug effects ; Osteoprotegerin/metabolism ; Phenotype ; Pulmonary Artery/pathology ; Pulmonary Artery/physiopathology ; Receptors, Interleukin-1/deficiency ; Receptors, Interleukin-1/metabolism ; TNF-Related Apoptosis-Inducing Ligand/metabolism ; Up-Regulation/drug effects ; Ventricular Function, Right/drug effects ; Ventricular Remodeling/drug effects